Literature DB >> 24091387

A Janus role for MerTK in the outcome of septic shock.

Massimo Girardis1, Andrea Cossarizza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24091387     DOI： 10.1007/s00134-013-3106-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages.

Authors:  Federica Alciato; Pier Paolo Sainaghi; Daniele Sola; Luigi Castello; Gian Carlo Avanzi
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury.

Authors:  Ye-Ji Lee; Ji-Young Han; Jiyeon Byun; Hyun-Jeong Park; Eun-Mi Park; Young Hae Chong; Min-Sun Cho; Jihee Lee Kang
Journal:  J Leukoc Biol       Date:  2012-03-16       Impact factor: 4.962

4.  Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.

Authors:  Gaetano Zizzo; Brendan A Hilliard; Marc Monestier; Philip L Cohen
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

5.  Increased MerTK expression in circulating innate immune cells of patients with septic shock.

Authors:  Caroline Guignant; Fabienne Venet; Séverine Planel; Julie Demaret; Aurélie Gouel-Chéron; Christophe Nougier; Arnaud Friggeri; Bernard Allaouchiche; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

Review 6.  Novel TACE inhibitors in drug discovery: a review of patented compounds.

Authors:  Prashant R Murumkar; Shirshendu DasGupta; Sneha R Chandani; Rajani Giridhar; Mange Ram Yadav
Journal:  Expert Opin Ther Pat       Date:  2010-01       Impact factor: 6.674

Review 7.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

8.  Prolonged apoptotic cell accumulation in germinal centers of Mer-deficient mice causes elevated B cell and CD4+ Th cell responses leading to autoantibody production.

Authors:  Tahsin N Khan; Eric B Wong; Chetna Soni; Ziaur S M Rahman
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

9.  The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Robert A Eisenberg; Philip L Cohen
Journal:  Clin Immunol       Date:  2009-07-24       Impact factor: 3.969

10.  Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation.

Authors:  Ji-Yeon Choi; Hyun-Jung Park; Ye-Ji Lee; Jiyeon Byun; Young-So Youn; Ji Ha Choi; So-Youn Woo; Jihee Lee Kang
Journal:  J Pharmacol Exp Ther       Date:  2012-11-29       Impact factor: 4.030
View more
  1 in total

Review 1.  Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.

Authors:  V Kumar
Journal:  Int Immunopharmacol       Date:  2020-10-12       Impact factor: 4.932
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.